Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma

Clinical trial NCT05759312 · UNKNOWN

Trial details

NCT number: NCT05759312
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Clear Cell Carcinoma

Start date: 2023-03-01
Primary completion: 2025-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.